These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 19114366)
1. [Correlation between magnetic resonance imaging findings and proliferating cell nuclear antigen expression in peripheral lung cancer]. Xiang ZM; Hu YS; Zhao SY; Tan LL; Li ZH Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2230-2. PubMed ID: 19114366 [TBL] [Abstract][Full Text] [Related]
2. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer. Gu C; Oyama T; Osaki T; Kohno K; Yasumoto K Anticancer Res; 2001; 21(4A):2357-62. PubMed ID: 11724293 [TBL] [Abstract][Full Text] [Related]
3. [Expression of apoptosis and proliferation related genes in carcinogenesis of lung squamous cell carcinoma in rats]. Wang J; Chen HL; Zhu RQ; Diao LM; Jang M; Yang F; Liu MQ Ai Zheng; 2003 May; 22(5):471-6. PubMed ID: 12753705 [TBL] [Abstract][Full Text] [Related]
4. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues]. Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209 [TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients. Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690 [TBL] [Abstract][Full Text] [Related]
7. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer. Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of proliferating cell nuclear antigen (PCNA) in supraglottic carcinoma. Liu M; Lawson G; Delos M; Jamart J; Remacle M Acta Otorhinolaryngol Belg; 1997; 51(3):129-35. PubMed ID: 9350310 [TBL] [Abstract][Full Text] [Related]
9. [Study on the correlation between CT features and expression of p53 protein and PCNA in peripheral lung cancer]. Chen J; Zhang H; Huang X Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):361-4. PubMed ID: 10921032 [TBL] [Abstract][Full Text] [Related]
10. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor. Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789 [TBL] [Abstract][Full Text] [Related]
11. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior]. Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062 [TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of PCNA and Caspase-3 in the tissue of lung cancer]. Zhao Y; Li XJ; Sui X; Tang XJ; Qin H; Ren H Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Feb; 26(2):154-6. PubMed ID: 20230677 [TBL] [Abstract][Full Text] [Related]
13. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma. Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668 [TBL] [Abstract][Full Text] [Related]
14. The implications of proliferation and apoptosis for lung cancer metastasis. Volm M; Koomagi R Oncol Rep; 1999; 6(2):373-6. PubMed ID: 10023008 [TBL] [Abstract][Full Text] [Related]
15. Correlation of proliferating cell nuclear antigen and bcl-2 expression with tumor front grading and metastasis in laryngeal squamous cell carcinoma. Boran C; Yildiz L; Kandemir B; Karagoz F; Baris S; Aydin O Neoplasma; 2003; 50(2):139-43. PubMed ID: 12740649 [TBL] [Abstract][Full Text] [Related]
16. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases. Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816 [TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of p53 and proliferating cell nuclear antigen in malignant tumor of maxillary sinus]. Xie RH; Chen ZH; Chen MY; Hou JH; Wu JH; Wu GH; Wu QL Ai Zheng; 2002 Nov; 21(11):1244-7. PubMed ID: 12526226 [TBL] [Abstract][Full Text] [Related]
18. [Correlation of GST-pi and PCNA expression to prognosis of advanced maxillary sinus squamous cell carcinoma]. Guo GF; Xie RH; Yang AK; Chen ZH; Wu QL; Liu WW; Ou SM; Xia LP; Chen MY; Zhang JX Ai Zheng; 2005 Oct; 24(10):1267-71. PubMed ID: 16219146 [TBL] [Abstract][Full Text] [Related]
19. [Expression of P53 and PCNA in nasopharyngeal carcinoma and their relation with clinical stage, VCA/IgA, EA/IgA, radiation sensibility, and pognosis]. Mo HY; Zhang CQ; Feng KT; Zhang F; Hong MH; Sun ZY Ai Zheng; 2004 Nov; 23(11 Suppl):1551-4. PubMed ID: 15566678 [TBL] [Abstract][Full Text] [Related]
20. Proliferating cell nuclear antigen (PCNA) expression in laryngeal squamous cell carcinomas. An immunohistochemical study. Kram A; DomagaĆa W Pol J Pathol; 1996; 47(4):183-7. PubMed ID: 9097710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]